136 related articles for article (PubMed ID: 35388711)
1. Sex-based differences in the outcomes of patients with lung carcinoids.
Abdel-Rahman O; Ghosh S; Fazio N
J Comp Eff Res; 2022 May; 11(7):523-531. PubMed ID: 35388711
[No Abstract] [Full Text] [Related]
2. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].
Correia Sda S; Pinto C; Bernardo J
Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291
[TBL] [Abstract][Full Text] [Related]
3. A Real-World Study of the Incidence and Outcomes of Early-Onset Well-differentiated Neuroendocrine Neoplasms.
Abdel-Rahman O; Ghosh S
Am J Clin Oncol; 2022 Aug; 45(8):338-343. PubMed ID: 35696696
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes for lung neuroendocrine tumors in California differ by sociodemographic factors.
Mulvey CK; Paciorek A; Moon F; Steiding P; Shih B; Gubens MA; Zhang L; Bergsland EK; Cheng I
Endocr Relat Cancer; 2024 Jan; 31(1):. PubMed ID: 37882324
[TBL] [Abstract][Full Text] [Related]
5. Incidence and Prognostic Significance of Carcinoid Lymph Node Metastases.
Kneuertz PJ; Kamel MK; Stiles BM; Lee BE; Rahouma M; Harrison SW; Altorki NK; Port JL
Ann Thorac Surg; 2018 Oct; 106(4):981-988. PubMed ID: 29908980
[TBL] [Abstract][Full Text] [Related]
6. Surgical Resection for Pulmonary Carcinoid: Long-Term Results of Multicentric Study-The Importance of Pathological N Status, More Than We Thought.
Cusumano G; Fournel L; Strano S; Damotte D; Charpentier MC; Galia A; Terminella A; Nicolosi M; Regnard JF; Alifano M
Lung; 2017 Dec; 195(6):789-798. PubMed ID: 29022070
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Disease-free Survival and Recurrence in Patients with Resected Bronchial Carcinoid Tumors.
Lee PC; Osakwe NC; Narula N; Port JL; Paul S; Stiles BM; Andrews WG; Nasar A; Altorki NK
Thorac Cardiovasc Surg; 2016 Mar; 64(2):159-65. PubMed ID: 25756243
[TBL] [Abstract][Full Text] [Related]
8. Typical and atypical pulmonary carcinoids : outcome in patients presenting with regional lymph node involvement.
Thomas CF; Tazelaar HD; Jett JR
Chest; 2001 Apr; 119(4):1143-50. PubMed ID: 11296182
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal carcinoids: characterization by site of origin and hormone production.
Onaitis MW; Kirshbom PM; Hayward TZ; Quayle FJ; Feldman JM; Seigler HF; Tyler DS
Ann Surg; 2000 Oct; 232(4):549-56. PubMed ID: 10998653
[TBL] [Abstract][Full Text] [Related]
10. Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors.
Robelin P; Hadoux J; Forestier J; Planchard D; Hervieu V; Berdelou A; Scoazec JY; Valette PJ; Leboulleux S; Ducreux M; Lombard-Bohas C; Baudin E; Walter T
J Thorac Oncol; 2019 Jun; 14(6):993-1002. PubMed ID: 30771520
[TBL] [Abstract][Full Text] [Related]
11. A Real-World, Population-Based Study for the Incidence and Outcomes of Neuroendocrine Neoplasms of Unknown Primary.
Abdel-Rahman O
Neuroendocrinology; 2021; 111(9):876-882. PubMed ID: 32980845
[TBL] [Abstract][Full Text] [Related]
12. The Cancers-Specific Survival of Metastatic Pulmonary Carcinoids and Sites of Distant Metastasis: A Population-Based Study.
Zhang J; Yu Q; He Y; Hu T; Chen K; Yang Z; Zhang X; Cheng D; He Z
Technol Cancer Res Treat; 2021; 20():15330338211036528. PubMed ID: 34378452
[TBL] [Abstract][Full Text] [Related]
13. Examination of factors associated with lymph node metastases in lung carcinoids: Results from a single institution retrospective cohort study.
Pathipati MP; Yohannan TK; Tian L; Hornbacker K; Benson JA; Berry GJ; Lui NS; Kunz PL; Padda SK
Lung Cancer; 2021 Apr; 154():186-194. PubMed ID: 33551175
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
Langfort R; Rudziński P; Burakowska B
Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment of the neuroendocrine tumors of the lung].
Gálffy G
Magy Onkol; 2018 Jul; 62(2):113-118. PubMed ID: 30027939
[TBL] [Abstract][Full Text] [Related]
16. Ascl1 and OTP tumour expressions are associated with disease-free survival in lung atypical carcinoids.
Centonze G; Maisonneuve P; Simbolo M; Lagano V; Grillo F; Prinzi N; Pusceddu S; Missiato L; Colantuono M; Sabella G; Bercich L; Mangogna A; Rolli L; Grisanti S; Benvenuti MR; Pastorino U; Roz L; Scarpa A; Berruti A; Capella C; Milione M
Histopathology; 2023 May; 82(6):870-884. PubMed ID: 36720841
[TBL] [Abstract][Full Text] [Related]
17. Secondary cancers after a lung carcinoid primary: a population-based analysis.
Cote ML; Wenzlaff AS; Philip PA; Schwartz AG
Lung Cancer; 2006 Jun; 52(3):273-9. PubMed ID: 16567020
[TBL] [Abstract][Full Text] [Related]
18. [Trends in prognostic factors for neuroendocrine lung tumors].
García-Yuste M; Molins L; Matilla JM; González-Aragoneses F; López-Pujol J; Ramos G; de la Torre M;
Arch Bronconeumol; 2007 Oct; 43(10):549-56. PubMed ID: 17939909
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531).
Mocellin S; Nitti D
Ann Oncol; 2013 Dec; 24(12):3040-4. PubMed ID: 24050954
[TBL] [Abstract][Full Text] [Related]
20. Is sublobar resection sufficient for carcinoid tumors?
Yendamuri S; Gold D; Jayaprakash V; Dexter E; Nwogu C; Demmy T
Ann Thorac Surg; 2011 Nov; 92(5):1774-8; discussion 1778-9. PubMed ID: 21704299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
